Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

NCT05478707 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

47

Enrollment

OTHER

Sponsor class

Stopped Institution transfer

Conditions

Diabetes Mellitus, Type 1
Endothelial Dysfunction

Interventions

DRUG: Dulaglutide
DRUG: Placebo

Sponsor

University of Virginia